Exertional dyspnea intensity is thought to reflect an increased awareness of neural respiratory drive, 40 indirectly measured using diaphragmatic electromyography (EMGdi). We examined the effects of 41 inspiratory muscle training (IMT) on dyspnea, EMGdi, and EMG of accessory inspiratory muscles. 42 IMT significantly reduced submaximal dyspnea intensity ratings but did not change EMG of any 43 inspiratory muscles. Improvements in exertional dyspnea following IMT may be the result of non-44 physiological factors or physiological adaptations unrelated to neural respiratory drive. 45 46 ABSTRACT 47 Inspiratory muscle training (IMT) has consistently been shown to reduce exertional dyspnea in 48 health and disease; however, the physiological mechanisms remain poorly understood. A growing body 49 of literature suggests that dyspnea intensity can largely be explained by an awareness of increased neural 50 respiratory drive, as indirectly measured using diaphragmatic electromyography (EMGdi). Accordingly, 51
Inspiratory muscle training (IMT) has been studied extensively in healthy individuals and 73 patients with chronic respiratory diseases but the efficacy of this intervention remains controversial (22, 74 30 ). Systematic reviews have concluded that IMT improves whole body exercise performance using a 75 range of performance based exercise tests (13, 16) but does not improve peak aerobic capacity or 76 maximal work rates during incremental exercise tests (13, 16) . The purported improvements in exercise 77 performance are thought to be related, at least in part, to reductions in exertional dyspnea ratings 78 (41) . While IMT can reduce dyspnea during both performance based and maximal incremental exercise 79 tests in health (13, 34) , the physiological mechanisms for this improvement have not been adequately 80 studied. 81
Previous research in health and disease has demonstrated a strong relationship between 82 diaphragmatic EMG (EMGdi), an indirect measure of neural respiratory drive (NRD), and dyspnea 83 intensity ratings (9, 18, 25, 38) . Moreover, the ratio between NRD and the mechanical output of the 84 respiratory system (i.e., neuromechanical coupling) is thought to be an important contributor to both the 85 intensity and qualitative dimensions of exertional dyspnea (28) . It follows that improvements in EMGdi 86 and neuromechanical coupling of the respiratory system can reduce dyspnea. Indeed, it has been 87 previously shown that bronchodilator-induced improvements in neuromechanical coupling in COPD are 88 correlated with improvements in dyspnea during exercise (28) . IMT may decrease the relative electrical 89 activation of the diaphragm and improve neuromechanical coupling of the respiratory system to perform 90 a given ventilatory task. Recent evidence also suggests that extradiaphragmatic inspiratory muscles, 91 such as the scalene and sternocleidomastoid muscles, are heavily recruited during IMT (31). Thus, 92 reductions in dyspnea following IMT may also be related to changes in the electrical activation of 93 extradiaphragmatic inspiratory muscles. Accordingly, the purpose of this study was to determine if IMT 94 reduces exertional dyspnea intensity ratings in healthy subjects and to determine if improvements in 95 dyspnea are related to improvements in inspiratory muscle EMG and neuromechanical coupling of the 96 respiratory system. We hypothesized that IMT would reduce dyspnea intensity ratings at submaximal 97 work rates, which would coincide with a reduction in EMG of the diaphragm, scalene and 98 sternocleidomastoid muscles with corresponding improvements in neuromechanical coupling of the 99 respiratory system. 100
101

METHODS 102
Subjects 103
Twenty-five young and healthy males participated in this study (ClinicalTrials.gov: 104 NCT02243527) . All subjects provided written informed consent and all procedures were approved by 105 the Providence Health Care Research Ethics Board at the University of British Columbia and adhered to 106 the Declaration of Helsinki. Inclusion criteria were as follows: male; self-reported physical activity 107 levels as 'moderate' or 'high' according to the International Physical Activity Questionnaire (5); 108 spirometry within normal limits; and able to read and understand English. Exclusion criteria were as 109 follows: current or former smokers; history or current symptoms of cardiopulmonary disease; 110 participating in competitive endurance sport at the provincial, national, or international level; ulcer or 111 tumour in the esophagus, a nasal septum deviation, or recent nasopharyngeal surgery; allergies to latex 112 or local anesthetics; and contraindications to exercise testing. 113
Experimental Overview 114
Subjects were randomly assigned to either an IMT (n=12) or sham control (SC) training (n=13) 115 program. Subjects completed 3 experimental visits and 5 weeks of training. Visit 1 (V1) served as a 116 detailed familiarization and screening visit where each subject performed pulmonary function testing 117 and a maximal incremental cycle exercise test. Visits 2 (V2) and 3 (V3) served as pre-and post-118 intervention measurements, respectively, and consisted of the same exercise test performed on V1. 119 Detailed ventilatory, EMG, respiratory mechanical, and sensory responses were measured throughout 120 exercise on V2 and V3. 121
Training 122
The IMT group were told they were a part of a 'respiratory muscle strength training ' intervention, 123 whereas the SC group were told they were part of a 'respiratory muscle endurance training' intervention. 124
Both IMT and SC groups performed their respective training with a POWERbreathe K3 device (HaB 125 International Ltd., Southam, Warwickshire, UK). The K3 model is a variable flow resistive device that 126 employs an electronically-controlled valve to apply a variable resistance over the course of inspiration. 127
The IMT group trained five days per week for five weeks, at two sessions per day (morning and 128 evening). Each session included 30 sharp inspiratory efforts from residual lung volume. The initial 129 intensity was set at 50% of the participant's MIP, determined on V2. Participants in the IMT group 130 were instructed to increase the training intensity freely, such that they were training at a 30-repetition 131 maximum intensity. The POWERbreathe K3 includes an inspiratory muscle warm-up for the first four 132 breaths, which were completed at an intensity less than the target training intensity. The next 26 133 repetitions were completed at the target intensity. Any repetition that failed to meet the target intensity 134 did not count towards the total completed repetitions for that session. The SC group also trained for a 135 total of five weeks but at a fixed intensity of 10% of MIP (from V2) once per day for a total of 60 136 repetitions, five days per week. Each training breath was described as being a slow, protracted, 137 deliberate breath. Previously, a 6-week intervention at 15% of MIP has been shown to be an effective 138 sham protocol that elicits no training effect (34). Both groups performed one supervised session per 139
week in the laboratory in order to monitor MIP and to gauge the appropriateness of their training 140 technique and intensity. The training intensity for the IMT group was increased if mouth pressures were 141 < 50% of current MIP or if subjects were, at the discretion of the research team, performing training 142 lower than a 30 repetition maximum. 143
Pulmonary Function and Maximal Inspiratory Pressure Measurements 144
Spirometry, plethysmography, and maximal inspiratory pressure (MIP) from residual volume 145 were collected according to previous recommendations (1, 26, 47) using a commercially available 146 testing system (Vmax Encore 229, V62J Autobox; CareFusion, Yorba Linda, CA) and expressed in 147 absolute terms and relative to predicted values (3, 12, 45, 49) . 148
Handgrip Strength 149
Handgrip strength was measured before and after training using a hand held dynamometer 150 (model 76618, Lafayette Instrument Company, Lafayette, IN) . This measure assessed each participant's 151 motivation to perform a maximal voluntary contraction. The maximal handgrip strength test involves 152 muscle groups unaffected by IMT. Therefore, an improvement in MIP without an increase in handgrip 153 strength was indicative of a physiological change in MIP, as opposed to a greater voluntary effort in 154 performing MIP manoeuvres. 155
Exercise Protocol 156
Subjects performed incremental exercise tests to exhaustion on an electronically braked cycle 157 ergometer (VIAsprint 200P; Ergoline, Bitz, Germany). Each test began with 6 minutes of steady state 158 rest, followed by a 1 minute warm up of unloaded pedalling. The incremental cycle test began at 25 W 159 and increased by 25 W every 2 minutes until volitional exhaustion. Participants pedalled at a freely 160 chosen cadence (> 60 rpm), and all ergometer measurements (i.e., saddle height, saddle position, 161 handlebar angle/height) were recorded and reproduced for all subsequent exercise tests. 162
Inspiratory Muscle EMG 163
Surface electrodes were used to assess EMG of the sternocleidomastoid (EMGscm) and scalene 164 (EMGsca) muscles as previously described (31). Briefly, bipolar electrodes on the scalenes were placed 165 within the posterior triangle of the neck, at the level of the cricoid cartilage (39). Electrodes were placed 166 along the long axis of the sternocleidomastoid muscle between the mastoid process and the medial 167 clavicle (40). The electrode placement was on the right side of the body and recorded in reference to 168 anatomical landmarks to ensure consistency in electrode placement between visits. A wireless surface 169 EMG system (TeleMyo DDTS; Noraxon USA, Inc., Scottsdale, AZ) was used to evaluate both 170 EMGscm and EMGsca. A combined esophageal electrode-balloon catheter was used to measure 171 EMGdi, which was connected to a bio-amplifier (bio-amplifier model RA-8; Yinghui Medical 172 Technology Co. Ltd., Guangzhou, China) (38). The catheter was inserted through the nares after 173 application of a topical anaesthetic (Lidodan® Endotracheal Spray; Odan Laboratories Ltd., Montréal, 174 QC, Canada). Position of the catheter was determined when the EMG amplitude was lowest in the 175 center pair and highest at the electrode pairs furthest from the center during spontaneous breathing (21). 176
The catheter was placed at the same depth and in the same nostril on both visits. All EMG data was 177 sampled at 2 kHz and the signals were further digitally processed using LabChart 7.3.7 Pro software 178 (ADInstruments Inc., Colorado Springs, CO) with a band-pass filter between 20 and 500 Hz. All raw 179 EMG data were converted to a root mean square using a time constant of 100 msec and a moving 180 window. In an effort to improve the signal-to-noise ratio in the EMGsca and EMGscm signals, the 181 average root mean square during expiration at baseline was subtracted from all subsequent EMG data. 182
All EMG data were expressed as a percentage of maximal EMG activity achieved during any inspiratory 183 capacity manoeuvre performed at rest or during exercise for a given experimental visit. 184
Cardiopulmonary Responses 185
Standard metabolic and ventilatory responses were measured on a breath-by-breath basis using a 186 commercially available metabolic cart (Vmax Encore 229, CareFusion, Yorba Linda, CA, USA). Heart 187 rate and arterial oxygen saturation were measured using a heart rate monitor (Polar T34; Polar Electro, 188 Kempele, Finland) and pulse oximeter (Radical-7 Pulse CO-Oximeter, Masimo Corporation, Irvine, CA, 189 USA), respectively. The inspiratory capacity manoeuvres used for EMG normalization purposes were 190 also used to calculate end-expiratory and end-inspiratory lung volumes (11) and were expressed as a 191 percentage of total lung capacity. Neuromechanical coupling of the respiratory system was determined 192 as the ratio between EMGdi (%max) and V T (%vital capacity). 193
Perceived Breathing and Leg Discomfort 194
Breathing discomfort, defined as "a feeling of laboured or difficult breathing" and leg discomfort, 195 defined as "the feeling of fatigue in [their] leg muscles", were measured using the modified 0-10 196 category ratio Borg Scale (2). The end points of the scale were anchored such that 0 represented "no 197 breathing/leg discomfort at all" and 10 represented "the most intense breathing/leg discomfort [they] 198 have every experienced or could ever imagine experiencing". Additionally, at the end of exercise, 199
participants were asked to: first, state their primary reason for stopping exercise (i.e., breathing 200 discomfort, leg discomfort, a combination of the two, or another reason) and to choose applicable 201 qualitative descriptors of breathlessness using a modified version of a previously published 202 questionnaire (42) that we have used previously (4). 203
Work of Breathing 204
The esophageal catheter used to measure EMGdi includes an esophageal balloon, which was 205 connected to a calibrated differential pressure transducer Validyne Engineering, 206 Northridge, CA, USA) to measure esophageal pressure. The total work of breathing (W b ) was 207 determined as the area within an averaged tidal esophageal pressure-volume loop including a portion of 208 a triangle that fell outside of the loop representing part of the elastic work of breathing (24). The W b 209 was then multiplied by breathing frequency. 210
Analysis of Exercise End-Points 211
All physiological exercise variables were averaged in 30 second epochs. The time between 60-90 212 seconds of each 2-minute stage was designated as our primary period of data collection. During this 213 time, participants were reminded to look straight forward, minimizing any head or neck movement, keep 214 a loose grip on the handlebars, and to avoid talking or swallowing to minimize contamination of our 215 outcomes of interest. The data obtained during this period was then linked to the breathing and leg 216 discomfort ratings and inspiratory capacity values that were collected during the last 30 seconds of each 217 stage (i.e., from 90-120 seconds). Analyses of EMG and W b were performed by a blinded assessor. 218
Blinding was achieved through assigning a random identifier to each stored data file during analysis and 219 removing the original file name that identified the subject group and visit. This was done to ensure 220 neutrality when processing data that may involve a bias of selection from the assessor, such as EMGdi 221 and esophageal pressure-volume loops for assessing the W b . Following analysis, all files were renamed 222 to their original identifier. 223
Statistical Analyses 224
An initial sample size calculation was performed on the basis of previous work (38) variables across work rates were tested using repeated measures analysis of variance with a Greenhouse-233
Geisser correction where appropriate. The between-subject factor tested was SC versus IMT group and 234 the within subject factor was work rate. First, the interaction term was evaluated. As no significant 235 interaction effects were observed in the current data, with the exception of MIP, only the between-236 subject factors were considered. These t-tests were performed on data collected at rest, standardized 237 absolute work rates, the highest equivalent work rate (HEWR) completed by an individual on both 238 visits, and at peak exercise, where peak exercise was defined as the highest work rate maintained for at 239 least 30 seconds. Changes in qualitative descriptors of dyspnea and reasons for stopping exercise were 240 performed with a paired McNemar's test. Significance was set at p < 0.05 and all data are presented as 241 mean ± SD. 242
243
RESULTS
244
Subject Characteristics 245
Subject characteristics and pulmonary function are presented in Table 1 . were well-matched for age, mass, pulmonary function, and physical activity levels. There were no 247 changes in self-reported physical activity when comparing pre vs. post intervention in both groups. 248
Peak exercise data can be found in Table 2 . There were no group differences in any baseline peak 249 exercise responses. There were no statistically significant changes in any peak exercise responses 250 following IMT or SC training. 251
Training 252
Adherence to interventions was good in both groups. The IMT group completed 94 ± 9% whereas 253 the SC group completed 88 ± 13% of assigned training sessions. Successful training sessions were 254 monitored digitally by the POWERbreathe device as well as via diary kept by the subject. In the event 255 of a discrepancy between the diary and POWERbreathe recordings of successful sessions, the 256 POWERbreathe data were used. This only occurred in one subject. MIP significantly increased after 257 five-weeks in the IMT group but not in the SC group (see also Table 1) . 258
Inspiratory Muscle EMG 259
Esophageal catheter-derived measures were obtained in 11 IMT and 11 SC subjects. EMGdi 260 during exercise before and after training are shown in Figure 1 (panels A and D). There were no 261 significant changes in EMGdi following training in both the IMT and SC groups at rest or during 262 exercise. The scalenes were relatively inactive throughout the early stages of exercise with EMGsca 263 activity increasing at the HEWR and peak exercise in both groups (Figure 1, This study is the first to comprehensively examine the neurophysiological mechanisms 287 associated with reduced dyspnea ratings following IMT in healthy human subjects. The main findings 288 are as follows: 1) Dyspnea intensity ratings were modestly reduced during submaximal exercise 289 intensities in the IMT but not in the SC group. Moreover, IMT had no effect on leg discomfort ratings 290 throughout exercise or on the qualitative dimensions of exertional dyspnea at maximal exercise; 2) IMT 291 had no effect on inspiratory muscle EMG; and 3) IMT had no effect on ventilatory responses, or 292 neuromechanical coupling of the respiratory system during incremental cycle exercise. Collectively, 293 these results suggest that modest improvements in dyspnea intensity ratings following IMT are not 294 explained by improvements in key physiological outcomes known to contribute to dyspnea in health and 295 disease. 296
Neural Respiratory Drive 297
Systematic reviews in healthy populations indicate a beneficial effect of IMT on dyspnea ratings 298 (13) . Despite this finding, it must be acknowledged that not all studies demonstrate a positive effect of 299 IMT on dyspnea (44, 48) and some studies, like ours, only show modest (i.e., < 1 Borg unit) decreases in 300 dyspnea (27) . Nevertheless, several mechanisms have been proposed to explain the apparent 301 improvement in dyspnea following IMT. The most commonly cited, but as of yet, untested mechanism, 302 is that motor outflow (i.e., "neural respiratory drive") decreases for any given level of minute ventilation 303
following IMT (14, 23) . This is a reasonable hypothesis given that dyspnea intensity ratings during 304 exercise are largely explained by an increased awareness of NRD (17, 18, 32, 38) . Huang et al. (15) 305 demonstrated that improvements in inspiratory muscle strength following IMT correlated with a 306 reduction in inspiratory motor command measured using mouth occlusion pressure at 0.1 s. This 307 correlation likely reflects a decrease in the percentage of motor units required for a given ventilatory 308 task. However, the study by Huang et al., (15) did not include a control group and did not evaluate 309 NRD during exercise or examine its association with exertional dyspnea. To our knowledge, the present 310 study is the first to examine the effects of IMT on NRD during exercise in healthy humans. The results 311 of our study suggest that IMT does not affect NRD, as indirectly estimated using invasive measures of 312 crural EMGdi during incremental cycling to exhaustion. A conference abstract based on 10 COPD 313 patients (7 IMT and 3 controls) demonstrated reductions in both EMGdi (by 12%) and dyspnea intensity 314 ratings (by 3.3 Borg scale units) at standardized ventilations during constant load cycling following 8 315 weeks of IMT (19). One potential explanation for this discrepancy is the fact that these COPD patients 316 had baseline inspiratory muscle weakness and may derive greater benefits from IMT compared to 317 healthy subjects that are not limited during exercise by dyspnea and that have normal baseline 318 inspiratory muscle strength. It is possible that strengthening the inspiratory muscles beyond a certain 319 point confers no additional advantage in reducing NRD during the hyperpnea of exercise. 320 321
Neuromechanical Coupling 322
Neuromechanical uncoupling of the respiratory system is thought to be an important contributor 323 to the intensity and qualitative dimensions of dyspnea (28, 29) . In general, the mechanical output of the 324 respiratory system increases proportionally to the level of NRD during exercise in healthy humans. 325
However, when V T becomes constrained or reaches a plateau/inflection, then the ratio between EMGdi 326 (%max) and V T (% vital capacity) begins to rise. This often leads to intolerable dyspnea and gives rise 327 to the sensation of "unsatisfied inspiration", particularly in patients with chronic respiratory disease that 328 have severe mechanical constraints on V T expansion (29). Given the lack of change in EMGdi and V T 329 in the present study, it is not surprising that there was no change in our measure of neuromechanical 330 coupling following IMT. 331
Extradiaphragmatic Inspiratory Muscles 332
There is some evidence to suggest that increases in dyspnea may be associated with 333 extradiaphragmatic inspiratory muscle activity (7) . Recent work also suggests that traditional 334 inspiratory muscle strength training protocols, as used in the present study, tend to preferentially recruit 335 extradiaphragmatic inspiratory muscles, particularly those in the neck (31). Thus, improvements in 336 global inspiratory muscle strength following IMT may be due to improvements in extradiaphragmatic 337 muscle strength (e.g., intercostal muscles, scalenes, sternocleidomastoids, etc.). We attempted to 338 address this question by examining changes in EMGscm and EMGsca during exercise. While we 339 observed a statistically significant reduction in EMGscm at one submaximal work rate, this was not 340 sustained throughout exercise and there were no changes in EMGsca at any exercise intensity. Based on 341 these data (Figure 1 ), we argue that there were no physiologically meaningful changes in EMGscm or 342 EMGsca following IMT. We have previously suggested that diaphragmatic recruitment can be 343 increased significantly if subjects consciously engage the diaphragm during IMT (31). We did not 344 employ this approach in the present study in order to facilitate comparisons with the majority of the IMT 345 literature in healthy subjects. Whether conscious recruitment of the diaphragm during IMT would 346 confer greater benefits on dyspnea and perhaps reduce EMGdi requires further investigation. 347
Alternative Mechanisms 348
Collectively, the results of this study show that IMT has no effect on any physiological 349 measurement related to the hyperpnea of exercise across the full range of ventilations (i.e., rest to 350 maximal exercise). Based on this observation, we speculate that modest decreases in dyspnea intensity 351 ratings following IMT may reflect some form of desensitization to repeated inspiratory muscle loading 352 over several weeks; changes that could not be captured in our physiological measurements during 353 exercise. However, this remains speculative and requires further investigation. Interestingly, we 354 observed no difference in leg discomfort ratings in the current study. This is inconsistent with Romer et 355 al. (34) Attenuation of respiratory muscle fatigue is another potential mechanism whereby IMT might 362 improve exertional dyspnea. Respiratory muscle fatigue results in a sympathetically mediated 363 metaboreflex response that reduces limb blood flow and increases perceptions of limb and respiratory 364 discomfort (6, 37). IMT has been shown to improve the fatigue-resistance of the inspiratory muscles 365 (35, 46) and can attenuate the respiratory muscle metaboreflex (50), which may explain, at least in part, 366 reduced dyspnea and leg discomfort ratings following IMT in previous studies. However, we do not 367 believe that diaphragm fatigue played a role in our dyspnea results given that we used an incremental 368 cycling protocol, which does not normally cause diaphragm fatigue (36). We intentionally selected 369 incremental rather than constant load cycling to track the sensory and physiological changes across the 370 full range of ventilations and to avoid the potential confounding effects of diaphragm fatigue on dyspnea 371 and NRD. Additional studies are needed to determine if respiratory muscle EMG can be reduced during 372 other exercise protocols such as time trials and constant-load exercise tests that are more likely to induce 373 respiratory muscle fatigue. 374
Limitations 375
This study has some limitations that must be acknowledged. First, limitations of using multi-pair 376 esophageal electrode catheters for assessing NRD are well established and have been described 377 elsewhere (20, 21, 38) . Second, we recognize that there is generally poor between-subject and between-378 occasion reproducibility of surface EMG measurements. Although reproducible inspiratory muscle 379 EMG during quiet resting breathing and inspiratory threshold loading has been established (8), this has, 380 to our knowledge, not been examined during exercise despite the widespread use of respiratory muscle 381 surface EMG during exercise (7, 33, 39) . We attempted to address this problem by carefully 382 standardizing the skin preparation procedures, placing the electrodes in the same position on all visits, 383 and normalizing the data to maximal inspiratory contractions. Third, surface EMG can be influenced by 384 underlying levels of subcutaneous fat. To overcome this limitation, we used lean subjects and we 385 measured skin-fold thickness of the neck and found no changes pre vs. post-training in either group 386 (data not shown). An additional critique is our decision to normalize all EMG data as a percentage of 387 maximum. This was done to standardize the procedures between our catheter derived EMG 388 measurements and our EMG measurements using surface electrodes. Some suggest that it is better to 389 report EMGdi in absolute values when comparing within-subject changes (25, 43) . We performed this 390 analysis (data not shown) and our conclusions regarding the lack of change in EMGdi remain the same. 391
Lastly, we acknowledge that there may have been "cross-talk" between our sternocleidomastoid and 392 scalene EMG measurements given the close proximity of these muscles. Thus, we are not able to 393 definitively say that we isolated these specific muscles with our surface electrodes. Nevertheless, our 394 surface EMG data provide a good global index of extradiaphragmatic inspiratory muscle activation 395 originating from the neck region. 396
Conclusions 397
Five weeks of inspiratory muscle strength training resulted in modest reductions in exertional 398 dyspnea intensity but did not change inspiratory muscle EMG, neuromechanical coupling of the 399 respiratory system, or the ventilatory response to exercise. Thus, improvements in dyspnea in healthy 400 individuals following IMT may be driven by non-physiological factors or by some physiological 401 outcomes that were not measured in the present study. Future work is needed to explore the 402 mechanisms of dyspnea relief following both strength and endurance based IMT using various exercise 403 protocols across the spectrum of health and disease. 404 405 406
